Written by the Nuvirox Research Team
Key points
- Red and near-infrared light therapy (photobiomodulation) has a genuinely stronger randomized-trial record for knee osteoarthritis than most at-home joint devices.
- A 2025 double-blind, sham-controlled RCT and multiple earlier trials show meaningful reductions in pain and improved function compared to placebo light.
- The evidence is strongest for short-to-medium-term pain relief; long-term structural effects on cartilage haven't been established.
Short answer: yes, with real randomized-trial support — red light therapy for knee osteoarthritis is one of the better-evidenced non-drug options in this category, though it's a symptom treatment, not a disease-modifying one. Photobiomodulation uses specific red and near-infrared wavelengths, usually in the 780-860 nm range, delivered by a laser or LED device pressed against the skin over the joint. The idea is that this light penetrates a few centimeters into tissue and influences mitochondrial activity in cells, which in turn is thought to reduce local inflammatory signaling. Unlike a lot of joint gadgets, this one has actual sham-controlled trials behind it — meaning study participants didn't know whether their device was really turned on.
What does a positive trial actually look like here?
One frequently cited study randomized 40 people with chronic knee osteoarthritis to real 850 nm low-level laser therapy or a visually identical placebo device, delivered twice weekly for four weeks. The active-treatment group showed significantly greater reductions in pain scores, WOMAC osteoarthritis index scores, and walking time compared to the sham group. A more recent double-blind RCT published in 2025 randomized 65 knee osteoarthritis patients into active photobiomodulation, sham, and untreated control arms and again found the active group came out ahead on pain and function measures, following CONSORT reporting standards for non-drug interventions.
A 2021 systematic review of randomized trials specifically looking at photobiomodulation combined with exercise programs found a consistent pattern across multiple studies: pain and functional capacity both improved more with active PBM plus exercise than with exercise alone. That's a meaningfully different, and more rigorous, evidence base than most joint-pain gadgets can claim — this isn't just enthusiastic testimonials, it's a repeated finding across sham-controlled trials from different research groups.
Study snapshot — Alghadir et al. 2014, Lasers Med Sci
| Design | Single-blind, sham-controlled RCT |
| N | 40 adults with chronic knee osteoarthritis |
| Protocol | 850nm LLLT, 6 J per point, twice weekly for 4 weeks |
| Outcome | VAS pain, WOMAC score, walking time |
| Finding | Significantly greater improvement vs. sham on all measures |
How does it supposedly work?
The leading mechanistic explanation involves cytochrome c oxidase, an enzyme in mitochondria that absorbs light in this wavelength range, potentially increasing cellular energy production and modulating local inflammatory mediators. This is well established in cell and animal studies; the honest caveat is that the exact translation from "changes something in a cell culture dish" to "reduces a person's knee pain" is still being worked out, and dosing parameters (wavelength, energy density, treatment frequency) vary meaningfully between the trials that show benefit and the handful that don't.
What it won't do
None of the cited trials show that photobiomodulation regenerates cartilage, reverses joint space narrowing, or halts osteoarthritis progression on imaging — the outcomes measured are pain and function, over weeks to a few months. Longer-term, disease-modifying claims aren't supported by the current trial record. It's also not a universal fix: some earlier, smaller trials found weaker or null results, and the effective dose (energy delivered per treatment point) matters — underdosed devices in real-world consumer products may not replicate clinical trial protocols.
If knee pain is accompanied by significant swelling, warmth, or a sudden change in symptoms, that's worth a clinical evaluation before adding any device-based approach, since those signs can point to something beyond routine osteoarthritis.
How it stacks up against other in-home options
Photobiomodulation is one of several non-drug, device-based approaches people try for knee osteoarthritis, and it's reasonable to ask how it compares. Our look at whether TENS units actually help joint pain covers a similarly popular device category with a much more contested trial record — genuinely useful context if you're deciding between the two. And because red light therapy's evidence is strongest when paired with movement rather than used alone, our guide to exercising with arthritic joints is worth reading alongside this one, since several of the positive PBM trials combined light therapy with a structured exercise program rather than testing the light in isolation.
Cost and consistency are also worth factoring in. Clinical-grade devices used in trials deliver a specific, measured energy dose per treatment point, and treatment schedules in the positive studies were fairly disciplined — two to three sessions a week for several weeks, not occasional or sporadic use. A consumer device used inconsistently, or at a lower output than what was tested, may reasonably be expected to underperform the trial results summarized above.
It's also worth being realistic about which knee osteoarthritis symptoms photobiomodulation is more or less likely to help. The trials cited above measured pain and self-reported function scores; they didn't measure or claim improvement in mechanical symptoms like locking, catching, or instability, which are more suggestive of a meniscus or ligament problem than inflammatory pain and typically don't respond to a light-based approach at all. If your knee symptoms include those mechanical features, that's worth mentioning to a doctor specifically, since photobiomodulation's evidence base doesn't extend to that category of complaint.
FAQ
Does red light therapy actually reduce knee osteoarthritis pain?
Multiple sham-controlled randomized trials, including a 2025 double-blind RCT, found meaningful reductions in pain and improved function compared to placebo light — one of the more consistently positive non-drug options studied for knee OA.
How long do the benefits from red light therapy last?
The trials generally measured outcomes over weeks to a few months of regular treatment. Long-term or permanent effects on the joint itself haven't been established.
What wavelength does the research use?
Most positive trials use red or near-infrared light in the roughly 780-860 nm range, delivered at specific energy doses per treatment point — consumer devices may not match these parameters exactly.
Can red light therapy replace treatment for arthritis?
No trial has tested it as a standalone replacement for standard osteoarthritis management. Most supporting studies combine it with, or compare it against, exercise programs rather than testing it in isolation as a cure.
From Nuvirox
Why we formulated Joint+ Restore
We built Joint+ Restore around the same principle this article is about: joint support only earns a place on the label if there's a defensible reason for it. We track the research on joint-supportive nutrients as it develops and formulate accordingly, rather than chasing trends — which is also why our formula is currently evolving as the evidence base does.
It comes with a 60-day money-back guarantee — long enough to actually judge whether it's doing anything for you.
Learn more about Joint+ Restore →The bottom line
Red light therapy for knee osteoarthritis has a genuinely better randomized, sham-controlled trial record than most joint-pain devices on the market, with a plausible cellular mechanism behind it. It's reasonable to view it as an evidence-supported option for symptom relief, alongside — not instead of — the basics like appropriate exercise and weight management, while keeping expectations calibrated to what's actually been measured: pain and function over the short-to-medium term.
References
- Alghadir A, Omar MTA, Al-Askar AB, Al-Muteri NK. Effect of low-level laser therapy in patients with chronic knee osteoarthritis: a single-blinded randomized clinical study. Lasers Med Sci. 2014;29(2):749-755. PMID: 23912778.
- Effect of photobiomodulation (low-level laser therapy) in patients with knee osteoarthritis: a randomized controlled trial. Lasers Med Sci. 2025;40(1):293. DOI: 10.1007/s10103-025-04542-4. PMID: 40545487.
- Association of photobiomodulation therapy (PBMT) and exercise programs in pain and functional capacity of patients with knee osteoarthritis: a systematic review of randomized trials. Lasers Med Sci. 2021;36(7):1341-1353. DOI: 10.1007/s10103-020-03223-8.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.